Study snapshot

Published
2025-01-23
Study design
Randomized controlled crossover feeding trial, with parallel blinded Limosilactobacillus reuteri or placebo arms
Population
Healthy adults without major chronic disease or recent antibiotic/probiotic exposure; 30 completed and plasma analyses used 29
Sample size
30
Duration
Three weeks on the prepared restore diet and three weeks on usual diet, separated by a three-week washout
Peer reviewed
Yes
Main reported result
The prepared restore diet caused short-term reductions in LDL cholesterol, fasting glucose and CRP compared with the usual-diet period in this sample.
Reported effect
LDL -16.8% (SD 15.8; p=0.003), fasting glucose -6.3% (SD 11.1; FDR-adjusted p<0.001), and CRP -14% (SD 58.3; FDR-adjusted p=0.014).
Important limitations
  • Small proof-of-concept trial with only 30 completers and no clinical disease outcomes.
  • The diet changed many foods and nutrients at once, so no ingredient gets sole credit.
  • Microbiome prediction and mediation analyses are not proof that microbes produced the cardiometabolic effects.
  • Participants were selected healthy volunteers; feasibility and effects in broader populations remain uncertain.
Funding
Weston Family Microbiome Initiative and PrecisionBiotics Group Ltd., with additional academic fellowship and infrastructure support.
Conflicts of interest
The tested PB-W1 strain is a PrecisionBiotics trademark and the company co-funded the work. A complete author declaration was not available in the accessible primary record at the source check, so that gap is disclosed here.

How this article was sourced

Selected from a date-audited 500-paper PubMed screening ledger, then checked against the primary paper record and supporting research before drafting.

This page explains one recent research result in context. It does not turn a study average, biomarker, or association into an individual diagnosis, treatment promise, or personal forecast.

A food experiment that controlled the menu

Most nutrition studies watch what people choose to eat. This one supplied a prepared diet. Thirty healthy Canadian adults completed both a three-week restore-diet period and a three-week usual-diet period, with a three-week washout between them. That crossover matters: each participant served as his or her own comparison, reducing some of the noise created by stable differences between people.

The restore menu was high in fiber and minimally processed foods, but it was a package rather than a single substitution. The experiment also included blinded probiotic and placebo arms. The headline cardiometabolic changes belonged to the diet comparison and did not require a probiotic win, an important distinction when a commercial bacterial strain sits beside a much broader food intervention.

Three fast changes, with three different meanings

LDL cholesterol fell by 16.8% during the restore-diet period, with a standard deviation of 15.8 percentage points. Fasting glucose fell 6.3%, with an SD of 11.1 points. Those are within-person short-term changes, not forecasts of heart attacks or diabetes. The glucose result also survived false-discovery-rate adjustment, but the trial was not designed to count future diagnoses.

CRP fell 14%, yet its SD was 58.3 percentage points, showing how widely responses varied. CRP is a useful inflammatory marker, not a disease outcome. Placing all three percentages on one chart is informative only if readers can see that their biological scales, variability and clinical implications differ. A larger percentage is not automatically the more important health effect.

Bar chart showing LDL down 16.8%, fasting glucose down 6.3%, and CRP down 14% during the three-week restore diet.
What changed during three weeks on the restore diet Mean change during the restore-diet period relative to the usual-diet period; all are short-term biomarkers. Data note: Reported means: LDL -16.8% (SD 15.8; p=0.003), fasting glucose -6.3% (SD 11.1; FDR-adjusted p<0.001), and CRP -14% (SD 58.3; FDR-adjusted p=0.014). Confidence intervals were not reported in the editorial packet and are not inferred. Credit: Unflame recreation from reported study data · License: Original data recreation Source: Cardiometabolic benefits of a non-industrialized-type diet are linked to gut microbiome modulation.
View accessible chart data
Data shown in What changed during three weeks on the restore diet
Group or point Value Note
LDL cholesterol -16.8 % change SD 15.8; p=0.003
Fasting glucose -6.3 % change SD 11.1; FDR-adjusted p<0.001
CRP -14.0 % change SD 58.3; FDR-adjusted p=0.014

Why no ingredient gets the trophy

The menu changed fiber, processing, plant variety and many other features at once. Controlled feeding strengthens the claim that the complete package produced the measured changes; it weakens any attempt to name one bean, grain, vegetable or omitted additive as the cause. Even perfect adherence cannot separate ingredients that were deliberately moved together.

That distinction also limits imitation. Readers cannot assume that buying one fermented food or fiber powder recreates the study. Other recent work has tested whole-food plant interventions and microbiota-dependent fiber responses, while observational research has examined gut-oriented diet scores. Those studies ask neighboring questions; none duplicates this three-week prepared menu or proves that its result transfers unchanged.

The microbiome is the clue, not the verdict

The researchers linked diet-related microbiome changes with cardiometabolic responses and used prediction and mediation analyses to explore possible pathways. Those methods can identify patterns worth testing. They cannot show that a microbial shift produced the LDL, glucose or CRP changes, because the food pattern was changing the host, nutrients and microbes at the same time.

Microbiome language can turn a careful feeding trial into a story about cultivating the right bacteria. The evidence does not reach that far. Fiber responses may depend on a person's starting microbial community, and large diet-microbiome associations remain observational. The defensible conclusion is narrower: the diet altered both microbial features and several biomarkers quickly, creating hypotheses for larger mechanistic trials.

A compelling proof of concept, not a prevention claim

Three weeks is long enough to demonstrate biological responsiveness and too short to establish durability. The volunteers were healthy and selected for a demanding feeding protocol. Whether people with chronic disease would respond similarly, whether households could sustain the menu, and whether the biomarker changes persist after food delivery stops are unanswered questions.

The funding also belongs in the story. PrecisionBiotics co-funded the work, and the tested PB-W1 strain is its trademark; the diet result itself was independent of a probiotic benefit. Readers should leave with a clean hierarchy: an unusually controlled diet experiment, several meaningful short-term marker changes, a plausible but unproven microbiome layer, and no evidence yet of fewer clinical events.

The next decisive study would keep the food control while enrolling more varied participants and following them after the supplied meals end. That combination could test whether the marker changes persist, whether responses differ by baseline health, and whether the microbiome adds predictive information beyond ordinary dietary and metabolic measurements.